T Cell Function in Chronic Idiopathic Urticaria
NCT01425593 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2012-11-06
Summary
Chronic idiopathic urticaria (CIU) is a common form of chronic urticaria in which the cause is not detected after intensive clinical and laboratory investigation.In view of the current data, it was suggested that at least part of the patients with CIU have an autoimmune process.This study is designed to investigate the mechanisms involved in the regulation and activation of the immune cells in patients with CIU and corelate them with disease activity
Conditions
- Chronic Urticaria
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2010-03-31
- Completion
- 2012-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria
NCT04827589 ·Status: WITHDRAWN ·Phase: PHASE2
-
Interleukin-2 for Refractory Chronic Spontaneous Urticaria
NCT06924762 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy Study of Canakinumab to Treat Urticaria
NCT01635127 ·Status: UNKNOWN ·Phase: PHASE2
-
Dupilumab in Chronic Spontaneous Urticaria
NCT03749135 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Endotypes of Chronic Idiopathic Urticaria
NCT04774315 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria
NCT02824393 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)
NCT01292473 ·Status: COMPLETED ·Phase: PHASE3
-
Profiling Urticaria for the Identification of Subtypes
NCT01637116 ·Status: COMPLETED
-
Platelet Activation in Chronic Inflammatory Skin Diseases
NCT01759693 ·Status: UNKNOWN
-
A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)
NCT00866788 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria
NCT04893980 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines
NCT05030311 ·Status: COMPLETED ·Phase: PHASE3
-
STOP CSUA: phySical acTivity, mOod and sleeP in Chronic Spontaneous Urticaria and Angioedema
NCT05169645 ·Status: UNKNOWN
-
Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)
NCT03111628 ·Status: COMPLETED ·Phase: PHASE4
-
Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
NCT03494881 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Monitoring Chronic Urticaria Basophil Irritability by Cytometry
NCT02671006 ·Status: COMPLETED
-
Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
NCT02550106 ·Status: COMPLETED ·Phase: PHASE4
-
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
NCT04681729 ·Status: COMPLETED ·Phase: PHASE3
-
Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
NCT06795373 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria
NCT04833855 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Circulating Innate Lymphoid Cells in Allergic Disorders
NCT03069495 ·Status: TERMINATED
-
Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
NCT01701583 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines
NCT05032157 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
NCT05405660 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment
NCT01287117 ·Status: COMPLETED ·Phase: PHASE3